These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 19958296

  • 21. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y, Li L, Xu G, Wang W.
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [Abstract] [Full Text] [Related]

  • 22. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK, Chang CK, Peng CH.
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH, Ng DS, Bakthavatsalam M, Chan VC, Young AL, Luk FO, Tsang CW, Brelén ME.
    Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
    [Abstract] [Full Text] [Related]

  • 25. Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy.
    Liu HY, Yang CH, Yang CM, Ho TC, Lin CP, Hsieh YT.
    Am J Ophthalmol; 2016 Jul; 167():57-64. PubMed ID: 27084002
    [Abstract] [Full Text] [Related]

  • 26. [Low-fluence photodynamic therapy in chronic central serous chorioretinopathy].
    Alcubierre R, Arias L, Lorenzo D, Pujol O, Rubio M.
    Arch Soc Esp Oftalmol; 2012 Jan; 87(1):3-8. PubMed ID: 22248651
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M.
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo A, Zagari M, Occhipinti F, Russo V, Reibaldi A, Longo A.
    Am J Ophthalmol; 2011 Jun; 151(6):953-960.e2. PubMed ID: 21457929
    [Abstract] [Full Text] [Related]

  • 32. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC, Dijkman G, Boon CJF.
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K, Shinoda K, Imamura Y, Matsumoto CS, Mizutani Y, Mizota A, Yuzawa M.
    Am J Ophthalmol; 2012 Sep; 154(3):579-85. PubMed ID: 22818904
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study.
    Breukink MB, Mohabati D, van Dijk EH, den Hollander AI, de Jong EK, Dijkman G, Keunen JE, Hoyng CB, Boon CJ.
    Acta Ophthalmol; 2016 Sep; 94(6):565-72. PubMed ID: 27149889
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Rouvas A, Stavrakas P, Theodossiadis PG, Stamatiou P, Milia M, Giannakaki E, Datseris I.
    Eur J Ophthalmol; 2012 Sep; 22(3):417-22. PubMed ID: 21928269
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A, Larsen M.
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.